Skip to content

MENU

HomeAboutAwardsScorecardsGeneral ResearchState-by-State ResearchCheat SheetsContact

Drug & Device Law

The definitive source for intelligent commentary on the law that matters for drug and device product liability cases

Home » The Brokers With Hands On Their Faces Blog

The Brokers With Hands On Their Faces Blog

Photo of Bexis
By Bexis on October 13, 2008
Posted in Other

We can’t resist.

(But we’re optimistic that today will be better.)

Print:
Email this postTweet this postLike this postShare this post on LinkedIn

Stay Connected

RSS Twitter

Bexis’ Book

Drug and Medical Device Product Liability Deskbook

Topics

  • Administrative Law
  • Alternative Dispute Resolution
  • Artificial Intelligence
  • Bellwether
  • Case Management
  • Causation
  • Choice of Law
  • Class Action
  • Class II Medical Devices
  • Class III Medical Devices
  • Clinical trials
  • Compliance Presumption
  • Consumer Protection
  • contributory negligence
  • Criminal
  • Cybersecurity
  • Design Defect
  • Discovery
  • Duty
  • Erie Doctrine
  • Evidence
  • Experts
  • Express Preemption
  • False Claims Act
  • FDA
  • Federal Diversity Jurisdiction
  • Federal Jurisdiction
  • Federal Question Jurisdiction
  • First Amendment
  • Forum non conveniens
  • Fraud
  • Fraudulent Joinder
  • Freedom of Information Act
  • Hospital Liability
  • Implied Preemption
  • Injunction
  • Innovator Liability
  • intervention
  • Joinder
  • Jurisprudence
  • Lanham Act
  • Learned Intermediary
  • Legislation
  • Lists
  • Manufacturing Defect
  • Medical Monitoring
  • Motions in Limine
  • Multidistrict Litigation
  • Negligent Design
  • Negligent Misrepresentation
  • North Carolina
  • Off-Label Use
  • Other
  • Parallel Violation Claims
  • Pari delicto
  • Personal Jurisdiction
  • Pleading
  • Preemption
  • Preliminary Injunction
  • Primary jurisdiction
  • Privilege
  • Punitive Damages
  • Removal
  • Res Ipsa Loquitur
  • RICO
  • Safer Alternative
  • Sanctions
  • Settlement
  • Standing
  • Statute Of Limitations
  • Statutes of Repose
  • Strict Liability
  • Strict Liability
  • Successor liability
  • Technology
  • Testing and Inspection
  • Third-Party Payer
  • Vaccines
  • Venue
  • Verdicts
  • Warnings
  • Warranty

Archives

Blogs

  • Abnormal Use
  • American Law Institute
  • Bill of Health
  • Cal Biz Lit
  • Class Action Blog
  • Class Action Countermeasures
  • Class Defense Blog
  • Drugwonks
  • Eye on FDA
  • Faegre Drinker on Products
  • FDA
  • FDA Law Blog
  • Federal Judicial Center
  • Food & Drug Law Access
  • Food Liability Law Blog
  • Guideposts
  • HIPAA Blog
  • Inside Medical Devices
  • JDSUPRA Business Advisor
  • Judicial Hellholes
  • Judicial Panel on Multidistrict Litigation
  • Life Sciences Legal Update
  • Mass Tort Defense
  • Mass Tort Litigation Blog
  • Medical Device Blog
  • Medical Devices Today
  • Modern Healthcare
  • National Library of Medicine/NIH
  • New Jersey Mass Tort Information Center
  • Overlawyered
  • Pharma Business Review
  • Pharma Exec Blog
  • Pharmaleaders
  • Point of Law
  • Pro Te: Solutio
  • Product Liability & Mass Torts Blog
  • Tort Talk
  • Torts Jotwell
  • Torts Prof
  • Wall Street Journal Health Blog
  • Wall Street Journal Law Blog
  • WLF Legal Pulse

Links & Resources

  • Adverse Event Report Cheat Sheet
  • Class Action Denial Federal Cheat Sheet
  • Class Action Denial State Cheat Sheet
  • Cross Jurisdictional Class Action Tolling Scorecard
  • Device Preemption Scorecard
  • Duty To Test Cheat Sheet
  • E-Discovery Cheat Sheet
  • Generic Drug Preemption Scorecard
  • Index of Posts
  • Lone Pine Cheat Sheet
  • No Injury Scorecard
  • Pioneer Defendant in Generic Drug Suit Scorecard
  • Post-Bauman Personal Jurisdiction Cheat Sheet
  • Post-Levine Drug/Vaccine Preemption Cheat Sheet
  • TwIqbal Cheat Sheet

Recent Updates

  • Magnuson Moss Cannot Be Applied Extraterritorially
  • Minnesota Court Holds that Dispute with Compounder is Preempted
  • Federal Preemption of State Attempts To Ban FDA-Approved Abortion Drugs After Dobbs
  • Plaintiff Loses Motion for New Trial in N.D. Illinois Hernia Mesh Case
  • FDCA-Based Negligence Per Se & Informed Consent Don’t Mix

Drug & Device Law

HomeAboutAwardsScorecardsGeneral ResearchState-by-State ResearchCheat SheetsContact
RSS Twitter
Disclaimer and Terms of Use

About this Blog

This blog contains the personal views of the Blogging Team identified below (and of any authors of guest posts) concerning various topics that arise in the defense of pharmaceutical and medical device product liability litigation. Read More
© 2022, Drug and Device Law. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo